Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in …
V Romanenko, I Osipova, A Galustyan… - Human Vaccines & …, 2020 - Taylor & Francis
We assessed the immunogenicity and safety of the combined diphtheria-tetanus-acellular
pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …
pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …
[HTML][HTML] Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy …
V Romanenko, I Osipova, A Galustyan… - Human Vaccines & …, 2020 - ncbi.nlm.nih.gov
We assessed the immunogenicity and safety of the combined diphtheria-tetanus-acellular
pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …
pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …
[PDF][PDF] Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy …
V Romanenko, I Osipova, A Galustyan, M Scherbakov… - 2020 - academia.edu
We assessed the immunogenicity and safety of the combined diphtheria-tetanus-acellular
pertussisinactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …
pertussisinactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in …
V Romanenko, I Osipova, A Galustyan… - Human Vaccines and …, 2020 - elibrary.ru
We assessed the immunogenicity and safety of the combined diphtheria-tetanus-acellular
pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …
pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in …
V Romanenko, I Osipova, A Galustyan… - Human Vaccines & …, 2020 - europepmc.org
We assessed the immunogenicity and safety of the combined diphtheria-tetanus-acellular
pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …
pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in …
V Romanenko, I Osipova… - Human vaccines & …, 2020 - pubmed.ncbi.nlm.nih.gov
We assessed the immunogenicity and safety of the combined diphtheria-tetanus-acellular
pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …
pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in …
V Romanenko, I Osipova, A Galustyan… - Human Vaccines and …, 2020 - elibrary.ru
This work was supported by GlaxoSmithKline Biologicals SA, including all costs associated
with the development and publication of this manuscript. The authors thank the children and …
with the development and publication of this manuscript. The authors thank the children and …